USA Non-Invasive Prenatal Testing Devices Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Non-Invasive Prenatal Testing Devices Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Type I Market Performance (Volume)
  • 2.1.2 Type II Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Type I Market Performance (Value)
  • 2.1.2 Type II Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Hospitals Market Performance (Volume)
  • 3.1.2 Clinics Market Performance (Volume)
  • 3.1.3 Research Laboratories Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 BGI Genomics
  • 4.1.1 BGI Genomics Profiles
  • 4.1.2 BGI Genomics Product Information
  • 4.1.3 BGI Genomics Non-Invasive Prenatal Testing Devices Business Performance
  • 4.1.4 BGI Genomics Non-Invasive Prenatal Testing Devices Business Development and Market Status
• 4.2 Illumina
  • 4.2.1 Illumina Profiles
  • 4.2.2 Illumina Product Information
  • 4.2.3 Illumina Non-Invasive Prenatal Testing Devices Business Performance
  • 4.2.4 Illumina Non-Invasive Prenatal Testing Devices Business Development and Market Status
• 4.3 LifeCodexx
  • 4.3.1 LifeCodexx Profiles
  • 4.3.2 LifeCodexx Product Information
  • 4.3.3 LifeCodexx Non-Invasive Prenatal Testing Devices Business Performance
  • 4.3.4 LifeCodexx Non-Invasive Prenatal Testing Devices Business Development and Market Status
• 4.4 Natera
  • 4.4.1 Natera Profiles
  • 4.4.2 Natera Product Information
  • 4.4.3 Natera Non-Invasive Prenatal Testing Devices Business Performance
  • 4.4.4 Natera Non-Invasive Prenatal Testing Devices Business Development and Market Status
• 4.5 Sequenom
  • 4.5.1 Sequenom Profiles
  • 4.5.2 Sequenom Product Information
  • 4.5.3 Sequenom Non-Invasive Prenatal Testing Devices Business Performance
  • 4.5.4 Sequenom Non-Invasive Prenatal Testing Devices Business Development and Market Status
• 4.6 Ariosa Diagnostics
  • 4.6.1 Ariosa Diagnostics Profiles
  • 4.6.2 Ariosa Diagnostics Product Information
  • 4.6.3 Ariosa Diagnostics Non-Invasive Prenatal Testing Devices Business Performance
  • 4.6.4 Ariosa Diagnostics Non-Invasive Prenatal Testing Devices Business Development and Market Status
• 4.7 Berry Genomics
  • 4.7.1 Berry Genomics Profiles
  • 4.7.2 Berry Genomics Product Information
  • 4.7.3 Berry Genomics Non-Invasive Prenatal Testing Devices Business Performance
  • 4.7.4 Berry Genomics Non-Invasive Prenatal Testing Devices Business Development and Market Status
• 4.8 CombiMatrix
  • 4.8.1 CombiMatrix Profiles
  • 4.8.2 CombiMatrix Product Information
  • 4.8.3 CombiMatrix Non-Invasive Prenatal Testing Devices Business Performance
  • 4.8.4 CombiMatrix Non-Invasive Prenatal Testing Devices Business Development and Market Status
• 4.9 F. Hoffmann-La Roche
  • 4.9.1 F. Hoffmann-La Roche Profiles
  • 4.9.2 F. Hoffmann-La Roche Product Information
  • 4.9.3 F. Hoffmann-La Roche Non-Invasive Prenatal Testing Devices Business Performance
  • 4.9.4 F. Hoffmann-La Roche Non-Invasive Prenatal Testing Devices Business Development and Market Status
• 4.10 Genpharm Services
  • 4.10.1 Genpharm Services Profiles
  • 4.10.2 Genpharm Services Product Information
  • 4.10.3 Genpharm Services Non-Invasive Prenatal Testing Devices Business Performance
  • 4.10.4 Genpharm Services Non-Invasive Prenatal Testing Devices Business Development and Market Status
• 4.11 Laboratory Corporation of America Holdings
• 4.12 LifeLabs Genetics
• 4.13 LifeCodexx
• 4.14 Natera
• 4.15 Sequenom

5 Market Performance for Manufacturers

• 5.1 USA Non-Invasive Prenatal Testing Devices Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 USA Non-Invasive Prenatal Testing Devices Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 USA Non-Invasive Prenatal Testing Devices Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 USA Non-Invasive Prenatal Testing Devices Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Northeast Market Performance for Manufacturers
  • 6.1.1 Northeast Non-Invasive Prenatal Testing Devices Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Northeast Non-Invasive Prenatal Testing Devices Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Northeast Non-Invasive Prenatal Testing Devices Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Northeast Non-Invasive Prenatal Testing Devices Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 Midwest Market Performance for Manufacturers
  • 6.2.1 Midwest Non-Invasive Prenatal Testing Devices Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 Midwest Non-Invasive Prenatal Testing Devices Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 Midwest Non-Invasive Prenatal Testing Devices Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 Midwest Non-Invasive Prenatal Testing Devices Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 South Market Performance for Manufacturers
  • 6.3.1 South Non-Invasive Prenatal Testing Devices Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 South Non-Invasive Prenatal Testing Devices Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 South Non-Invasive Prenatal Testing Devices Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 South Non-Invasive Prenatal Testing Devices Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 West Market Performance for Manufacturers
  • 6.4.1 West Non-Invasive Prenatal Testing Devices Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 West Non-Invasive Prenatal Testing Devices Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 West Non-Invasive Prenatal Testing Devices Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 West Non-Invasive Prenatal Testing Devices Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration

7 USA Non-Invasive Prenatal Testing Devices Market Performance (Sales Point)

• 7.1 USA Non-Invasive Prenatal Testing Devices Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 USA Non-Invasive Prenatal Testing Devices Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 USA Non-Invasive Prenatal Testing Devices Price (USD/Unit) by Regions 2013-2018
• 7.4 USA Non-Invasive Prenatal Testing Devices Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 USA Non-Invasive Prenatal Testing Devices Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Northeast Non-Invasive Prenatal Testing Devices Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 Midwest Non-Invasive Prenatal Testing Devices Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 South Non-Invasive Prenatal Testing Devices Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 West Non-Invasive Prenatal Testing Devices Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Hospitals Industry
• 11.2 Clinics Industry
• 11.3 Research Laboratories Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 USA Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 USA Non-Invasive Prenatal Testing Devices Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Northeast Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 Midwest Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 South Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 West Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Hospitals Sales and and Growth Rate 2019-2024
  • 12.4.3 Clinics Sales and and Growth Rate 2019-2024
  • 12.4.4 Research Laboratories Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 USA Non-Invasive Prenatal Testing Devices Price (USD/Unit) Trend 2019-2024
  • 12.5.2 USA Non-Invasive Prenatal Testing Devices Gross Profit Trend 2019-2024

13 Conclusion